Allena Pharmaceuticals Announces $10.0 Million Bought Deal Offering
NEWTON, Mass., Dec. 01, 2020 (GLOBE NEWSWIRE) — Allena Pharmaceuticals, Inc. (NASDAQ: ALNA), a late-stage,…
News
Leading Independent Proxy Firms ISS and Glass Lewis Recommend Ocugen Stockholders Vote “FOR” Reverse Stock Split and Authorized Shares Amendment Proposals
MALVERN, Pa., Dec. 01, 2020 (GLOBE NEWSWIRE) — Ocugen, Inc. (NASDAQ: OCGN), a biopharmaceutical company…
Burning Rock Announces Proposed Registered Secondary Public Offering of American Depositary Shares
GUANGZHOU, China, Dec. 01, 2020 (GLOBE NEWSWIRE) — Burning Rock Biotech Limited (NASDAQ: BNR, the…
Cambium Networks Corporation Announces Launch of Secondary Offering
ROLLING MEADOWS, Ill., Dec. 01, 2020 (GLOBE NEWSWIRE) — Cambium Networks Corporation (Nasdaq: CMBM) (“Cambium”),…
Optinose Announces Changes to Board of Directors
YARDLEY, Pa., Dec. 01, 2020 (GLOBE NEWSWIRE) — Optinose (NASDAQ:OPTN), a pharmaceutical company focused on…
Travere Therapeutics to Host Virtual R&D Day on Wednesday, December 9, 2020
SAN DIEGO, Dec. 01, 2020 (GLOBE NEWSWIRE) — Travere Therapeutics (NASDAQ: TVTX) today announced that…
Data from Long-Term Safety Study Support Chronic Use of ARQ-151 (Topical Roflumilast Cream) as a Potential Treatment for Plaque Psoriasis
Once-daily roflumilast cream demonstrated favorable safety and tolerability over 52 to 64 weeks of treatment…
Paratek Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
BOSTON, Dec. 01, 2020 (GLOBE NEWSWIRE) — Paratek Pharmaceuticals, Inc. (Nasdaq: PRTK), a commercial-stage biopharmaceutical…
BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
RESEARCH TRIANGLE PARK, N.C., Dec. 01, 2020 (GLOBE NEWSWIRE) — BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today…
Syneos Health Announces Secondary Offering of Common Stock
MORRISVILLE, N.C., Dec. 01, 2020 (GLOBE NEWSWIRE) — Syneos Health, Inc. (Nasdaq: SYNH) (the “Company”…